Hepatitis C virus infection protein network
B de Chassey1,2,a, V Navratil2,3,a, L Tafforeau1,2,a, M S Hiet1,2,a, A Aublin-Gex1,2, S Agaugué1,2,a, G Meiffren1,2, F Pradezynski1,2, B F Faria1,2, T Chantier1,2, M Le Breton1,2, J Pellet1,2, N Davoust1,2, P E Mangeot1,2, A Chaboud2,4, F Penin2,4, Y Jacob5, P O Vidalain6, M Vidal7, P André1,2,8, C Rabourdin-Combe1,2 & V Lotteau1,2,8
- IMAP Team, Inserm Unit 851, Lyon, France
- IFR128 BioSciences Lyon-Gerland, Université de Lyon, Lyon, France
- INRA UMR 754, rétrovirus et pathologie comparée, Lyon, France
- Institut de Biologie et Chimie des Protéines, CNRS UMR 5086, Lyon, France
- Unité Postulante de Génétique, Papillomavirus et Cancer Humain, Institut Pasteur, Paris, France
- Laboratoire de Génomique Virale et Vaccination, Institut Pasteur, CNRS URA 3015, Paris, France
- Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
- Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Laboratoire de virologie, Lyon, France
Correspondence to: V Lotteau1,2,8 IMAP Team, Inserm Unit 851, 21, Av. T. Garnier, Lyon 69007, France. Tel.: +33 437 282 412; Fax: +33 437 282 341; Email: vincent.lotteau@inserm.fr
Received 22 April 2008; Accepted 30 September 2008; Published online 4 November 2008
aThese authors contributed equally to this work
aPresent address: Department for Molecular Virology, University of Heidelberg, Heidelberg 69120, Germany.
aPresent address: Service de Recherches en Hémato-Immunologie, CEA-DSV-DRM, Hôpital Saint-Louis, IUH, Paris 75475, France.
Top of pageArticle highlights
- Identification of 481 pairwise protein interactions between HCV and human proteins by yeast two-hybrid screening and extensive literature mining.
- The integration analysis of HCV-interacting proteins within the cellular protein network revealed their essential topological feature such as high local and global centrality.
- Analysis of cellular interactors in regards to functional annotation pathways showed the enrichment of three major pathways (insulin, Jak/STAT and TGF
) associated with the most frequent HCV clinical syndromes. A human sub-network centered on these pathways shed a new light on the molecular basis of their co-deregulation during infection. - The focal adhesion pathway, related to tumor progression, was also highly targeted by HCV and functionally impaired.
Synopsis
Hepatitis C virus (HCV) infection concerns 170 millions of individuals worldwide. Chronically infected patients present liver injury essentially mediated by immune mechanisms and metabolic disorders associated with hepatic steatosis, fibrogenesis and insulin resistance. Long-term-infected patients have a high risk of developing cirrhosis and hepatocarcinoma. Molecular basis of HCV pathology remains poorly understood. HCV genome is a positive-strand RNA of 9.6 kb encoding a polyprotein post-translationally processed into structural (CORE, E1, E2 and p7) and non-structural (NS2, NS3, NS4A, NS4B, NS5A and NS5B) proteins (Appel et al, 2006). Here, a proteome-wide mapping approach of interactions between HCV and cellular proteins was performed to provide a comprehensive view of viral infection. Viral baits were screened against human cDNA libraries using a highly stringent yeast two-hybrid assay (Y2H). Together with literature, the resulting HCV–human interactome is composed of 481 protein–protein interactions (PPIs) with 65% new interactions, involving 421 human proteins. NS3, NS5A and CORE are the most connected proteins, with 214, 96 and 76 cellular partners, respectively, highlighting the potential multi-functionality of these proteins during infection. A human PPI network, reconstructed from eight databases and composed of 44 223 non-redundant PPIs between 9520 different cellular proteins, revealed that cellular proteins interacting with HCV (HHCV) are strongly interconnected (Figure 1).
Figure 1
The HCV interaction network. (A) Nomenclature. V: viral protein (black node). HHCV: human protein interacting with HCV proteins (red node). HNot-HCV: human protein not interacting with HCV proteins (blue node). V-HHCV: HCV–human protein interaction (red edge). HHCV–HHCV: interaction between HCV-interacting human proteins (blue edge). H–H: human–human protein interaction (blue edges). V-HHCV represents the interactions between HCV and human proteins (black box). HHCV–HHCV is composed of human proteins interacting with viral proteins (red box). H–H network represents interactions between human proteins (blue box). (B) Number of proteins and interactions in HCV–human interaction network. Number of human proteins interacting with HCV proteins (HHCV) and corresponding number of protein–protein interactions (V-HHCV PPI). Data are given for our yeast two-hybrid screens (IMAP Y2H) and for literature-curated interactions (IMAP LCI). (C) Validation of Y2H interactions by co-affinity purification assay. Nine out of 22 positive co-AP assays are shown, representing the following: NS5A-SORBS2, NS3-CALCOCO2, NS5A-BIN1, NS5A-MOBK1B, NS5A-EFEMP1, NS3-PSMB9 and NS5A-PSMB9, NS5A-PPPIRI3L, NS3-RASAL2. After pull-down with GST-tagged viral baits or with negative-control GST alone cellular preys are identified with anti-Flag antibody. Anti-GST antibody identifies either GST-alone or GST-tagged viral baits. Expression of cellular preys in cell lysate is controlled by anti-Flag (bottom panel). (D) Number of interactions by viral protein.
Full figure and legend (298K)Figures & Tables indexTopological analysis of the HCV–human interaction network
To assess how HCV proteins interplay with the cellular protein network, we focused on the centrality measures of HHCV proteins in the human interactome. The degree of a protein corresponds to its number of direct partners and is therefore a measure of local centrality. The betweenness is a global measure of centrality that represents the information flow in the network. Comparing these values computed for HHCV and for cellular proteins that do not interact with HCV indicates that HCV proteins have a strong tendency to interact with highly connected cellular proteins. Similar results were observed with human proteins interacting with Epstein–Barr virus proteins, suggesting that preferential attachment on central proteins may be a general hallmark of viral proteins (Calderwood et al, 2007). As the high centrality of proteins was previously shown to correlate with their functional essentiality, the data suggest that HCV proteins tend to interact with essential proteins in the cell.
Functional analysis of the HCV–human interaction network
Analysis of the data set revealed the specific targeting of three pathways associated with HCV clinical syndromes (insulin, TGF
and Jak/STAT pathways) and identified focal adhesion as a novel pathway affected by HCV.
IJT network (insulin–Jak/STAT–TGF
network)
Chronic infection by HCV is associated with an increased risk for metabolic disorders with development of steatosis. Although insulin, TGF
and Jak/STAT pathways have been suspected to be involved in these clinical features, their related perturbation during HCV infection remains unexplained (Romero-Gomez, 2006). We thus used a network approach to identify cellular proteins targeted by HCV and localized at the interface of these pathways. The resulting interaction map was constructed to form the IJT network (insulin–Jak/STAT–TGF
network; Figure 4).
Figure 4
IJT network. (A) Graphical representation of IJT network. Protein (nodes) members of insulin (blue), Jak/STAT (red) and TGF
(green) pathways according to KEGG annotation, and their interactions (edges) are shown (proteins interacting with HCV proteins are named). Proteins shared by two pathways are shown in secondary colours (pink, yellow and cyan). Grey and black nodes are neighbours that connect the KEGG pathways and that interact with HCV proteins (grey: protein from the IMAP Y2H data set; black: protein from the IMAP LCI data set). Neighbours interacting with HCV but not connecting the KEGG pathways are not represented. Discussed protein examples PLSCR1 and YY1 are in box. References to visualization tools are provided in supplementary files (network visualization). IJT network construction in Supplementary methods. (B) Relative contribution of each viral protein in V–HHCV. Percentage interactions for the three most interacting viral proteins, relative to the total number of interactions as listed in Supplementary Table SI, are shown. A total of 51.3% of CORE interactions are concentrated in the IJT network. (C) Relative contribution of each viral protein in IJT network. Percentage interactions for the three most interacting viral proteins, relative to the total number of viral protein interactions with proteins of IJT network, are shown.
Interaction of interface proteins with HCV proteins may induce functional perturbations that could expand to adjacent pathways. One of these proteins is the nuclear factor Yin Yang 1 (YY1), which exhibits a central position in the IJT network as it connects the three pathways. HCV CORE interaction with YY1 has been previously shown to be functional relieving NPM1 expression. This observation could be extrapolated to PPAR
expression and SMADs transcriptional activity in support of insulin and TGF
pathway modulation (Kurisaki et al, 2003; Mai et al, 2006; He et al, 2008). This is only one illustrative example of cellular target most likely to be involved in HCV-induced phenotypes. Many of the proteins at the interface are known to have an important function in the regulation of one, two or the three pathways without being officially annotated. The clinical phenotypes observed in chronic HCV infection are most likely to result from the integrative effect of protein interactions depicted in the IJT network.
Another issue that became apparent in the IJT network is that CORE appears as a major perturbator of the IJT network. Interestingly, transgenic mice expressing CORE develop insulin resistance (Pazienza et al, 2007). The IJT network provides a powerful tool to investigate the impact of CORE in HCV-associated metabolic disorders. It is also worth considering that the IJT network may identify a series of genes involved in diseases, such as steatosis and fibrogenesis, in the absence of viral infection.
Focal adhesion
Focal adhesion was specifically targeted by NS3 and NS5A proteins. Integrin-linked focal adhesion complexes control cell adhesion to extracellular matrix (ECM). Upon binding to the ECM, both
and
integrin subunits recruit proteins establishing a physical link between the actin-cytoskeleton and signal transduction pathways. When deregulated, this functional process can lead to detachment from ECM and tumour initiation. An adhesion assay was performed that demonstrates that, when transfected, NS3 and NS5A specifically affected adhesion of cells on fibronectin and thus could participate in tumour initiation and progression.
In a network approach of HCV infection, the interaction map identifies all potential connections needed for the virus to replicate and escape host defence. A fascinating challenge of this approach is to identify molecular signatures common to several viruses at the protein network level and to discover the vulnerable points to develop original large-spectrum anti-viral molecules. This will, however, necessitate the integration of system-level data sets of different origins that will set the stage for the complex systems analysis of viral infections.
Acknowledgements
This work was funded by ANRS, INSERM and the French Ministry of Industry. We acknowledge L Meyniel for critical reading of the manuscript. We also acknowledge Lyon Biopöle. V Navratil is supported by a grant from INRA.
References
- Appel N, Schaller T, Penin F, Bartenschlager R (2006) From structure to function: new insights into hepatitis C virus RNA replication. J Biol Chem 281: 9833–9836 | Article | PubMed | ChemPort |
- Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, Holthaus AM, Ewence AE, Li N, Hirozane-Kishikawa T, Hill DE, Vidal M, Kieff E, Johannsen E (2007) Epstein–Barr virus and virus human protein interaction maps. Proc Natl Acad Sci USA 104: 7606–7611 | Article | PubMed | ADS | ChemPort |
- He CQ, Ding NZ, Fan W (2008) YY1 repressing peroxisome proliferator-activated receptor delta promoter. Mol Cell Biochem 308: 247–252 | Article | PubMed | ChemPort |
- Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A (2003) Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol Cell Biol 23: 4494–4510 | Article | PubMed | ISI | ChemPort |
- Mai RT, Yeh TS, Kao CF, Sun SK, Huang HH, Wu Lee YH (2006) Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression. Oncogene 25: 448–462 | Article | PubMed | ChemPort |
- Pazienza V, Clement S, Pugnale P, Conzelman S, Foti M, Mangia A, Negro F (2007) The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 45: 1164–1171 | Article | PubMed | ChemPort |
- Romero-Gomez M (2006) Insulin resistance and hepatitis C. World J Gastroenterol 12: 7075–7080 | PubMed | ISI | ChemPort |


